ArticleActa diabetologica2024

Use of teplizumab in children and adolescents at risk of type 1 diabetes: perspectives of parents and caregivers from an Italian Pediatric Diabetes Center.

Bruno Bombaci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.